CAS 1013920-15-4

Vorolanib

CAS : 1013920-15-4

Vorolanib

Degré de pureté : ≥95%

Masse moléculaire : 439.48g/mol

Ref: 54-BUP04294

Vorolanib-d6

CAS : 1013920-15-4

Formule : C₂₃H₂₀D₆FN₅O₃

Masse moléculaire : 445.53

Ref: 4Z-V-094002

Vorolanib

CAS : 1013920-15-4

Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor.

Formule : C₂₃H₂₆FN₅O₃

Degré de pureté : 97.35%

Couleur et forme : Solid

Masse moléculaire : 439.48

Ref: TM-T8491

Vorolanib

CAS : 1013920-15-4

Formule : C₂₃H₂₆FN₅O₃

Masse moléculaire : 439.49

Ref: 4Z-V-094001

Vorolanib-D6

Produit contrôlé

CAS : 1013920-15-4

Formule : C₂₃H₂₀D₆FN₅O₃

Couleur et forme : Neat

Masse moléculaire : 445.53

Ref: TR-V766027

Vorolanib

Produit contrôlé

CAS : 1013920-15-4

Formule : C₂₃H₂₆N₅O₃F

Couleur et forme : Neat

Masse moléculaire : 439.48

Ref: TR-V766025

X-82 (Vorolanib)

CAS : 1013920-15-4

Vorolanib is a small molecule that binds to the death receptor 4 (DR4) and inhibits angiogenesis. Vorolanib is a member of the everolimus group. This drug has been shown to inhibit tumor growth in a mouse model of metastatic cancer by blocking the activation of DR4, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib has also been shown to have anti-inflammatory properties. Vorolanib binds to the death receptor 4 (DR4) and inhibits angiogenesis by blocking activation of this protein, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib also has anti-inflammatory properties due to its ability to suppress myeloid derived suppressor cells (MDSCs).

Formule : C₂₃H₂₆FN₅O₃

Degré de pureté : Min. 95%

Masse moléculaire : 439.4 g/mol

Ref: 3D-NQB92015